Cite
HARVARD Citation
Malik, I. et al. (2022). Glucagon‐like peptide‐1, glucose‐dependent insulinotropic polypeptide, and glucagon receptor poly‐agonists: a new era in obesity pharmacotherapy. Obesity. 30 (9), pp. 1718-1721. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Malik, I. et al. (2022). Glucagon‐like peptide‐1, glucose‐dependent insulinotropic polypeptide, and glucagon receptor poly‐agonists: a new era in obesity pharmacotherapy. Obesity. 30 (9), pp. 1718-1721. [Online].